James Engleback

James Engleback is a Senior Scientist at Sygnature Discovery since October 2022 and is currently pursuing a PhD at the University of Manchester, a role that began in September 2017. Previously, James worked as a Protein Design Scientist at Mellizyme Biotechnology from April 2021 to April 2022 and was part of the iGEM - Manchester 2017 team at The University of Manchester during November 2016 to November 2017. Additionally, James contributed to herbicide screening at Syngenta from August 2015 to August 2016. Academic qualifications include a PhD in Biotech from the University of Manchester, achieved in July 2022, and a B.Sc. in Biology from the same institution, completed in 2017.